One big mistake was BAL didn't lodge CFDA/SAMR earlier.
If BAL were lodging earlier like A2M, probably got approval last year as initial approval procedures were much easier and less restricted, imo.
BAL Price at posting:
$8.30 Sentiment: Buy Disclosure: Not Held